MDL | - |
---|---|
Molecular Weight | 462.50 |
Molecular Formula | C25H26N4O5 |
SMILES | O=C(C1=NN=C(C2=CC=C(OC)C=C2)O1)N3CC(OC4=CC=C(CN(C5)CC65COC6)C=C4)C3 |
AZD1979 is a Melanin-concentrating hormone receptor 1 ( MCHr1 ) antagonist with an IC 50 of ~12 nM.
IC50: ~12 nM (MCHr1) [1]
In DIO mice, initial AZD1979-mediate body weight loss is driven by decreasing food intake, but an additional component of preserving energy expenditure is apparent in pair-feeding and indirect calorimetry studies. AZD1979 also dose-dependently reduces body weight in dogs [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02072993 | AstraZeneca |
Healthy Subjects
|
March 2014 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 33.33 mg/mL ( 72.06 mM ; ultrasonic and warming and heat to 60°C)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.1622 mL | 10.8108 mL | 21.6216 mL |
5 mM | 0.4324 mL | 2.1622 mL | 4.3243 mL |
10 mM | 0.2162 mL | 1.0811 mL | 2.1622 mL |